Dorkenoo, Ameyo Monique
Warsame, Marian
Ataba, Essoham
Hemou, Manani
Yakpa, Kossi
Sossou, Efoe
Mitigmsagou, M’badi
Teou, Carmel Diwaba
Caspar, Emmanuelle
Ma, Laurence
Djadou, Koffi Edem
Atcha-Oubou, Tinah
Rasmussen, Charlotte
Menard, Didier
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021
https://0-doi-org.brum.beds.ac.uk/10.1186/s12936-024-04922-1
Article History
Received: 27 October 2023
Accepted: 27 March 2024
First Online: 3 April 2024
Declarations
:
: The study protocol was reviewed and approved by the Ministry of Health, Public Hygiene, and Universal Health Coverage. Written informed consent was obtained from the adult patients, parents, or guardians of the children before enrollment in the study.
: Not applicable.
: The authors declare that they have no conflict of interest.